|
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are Verona Pharma Plc
attached:ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights ü
An acquisition or disposal of qualifying financial instruments which may result
in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to
qualifying financial instruments
An event changing the breakdown of voting rights ü
Other (please specify):
3. Full name of person(s) subject to the FMR LLC
notification obligation:iii
4. Full name of shareholder(s) See attached schedule
(if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or 11 January 2012
reached: v
6. Date on which issuer notified: 13 January 2012
7. Threshold(s) that is/are crossed or 5%
reached: vi, vii
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of Situation previous Resulting situation after the triggering
shares to the triggering transaction
transaction
if possible Number Number Number Number of voting % of voting rights
using of of of shares rights x
the ISIN CODE Shares Voting
Rights Indirect Direct Indirect Direct Indirect
xi xii
GB00B06GSH43
11,883,179 11,883,179 18,383,179 18,383,179 5.98
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period xiv rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting rights % of voting
financial price date xvii Conversion instrument refers to rights xix, xx
instrument period xviii
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
18,383,179 5.98
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
See attached schedule
Proxy Voting:
10. Name of the proxy holder: FIL Limited
11. Number of voting rights proxy holder will acquire: 6,500,000
12. Date on which proxy holder will acquire voting rights: 11 January 2012
13. Additional Filing due to the placing of shares 6,500,000 fully placed on
information: 11/01/2012
14. Contact name: Philip Alexander
15. Contact telephone
number: fil-regreporting@fil.com / 01737 834624
END
More
|
